FFO
RMTI icon

Fortitude Family Office’s Rockwell Medical RMTI Stock Holding History

Fortitude Family Office’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50
Closed -$413 – 2042
2025
Q4 		$413 Buy
+50
New +$505 ﹤0.01% 1768

Other funds holding RMTI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Fortitude Family Office's RMTI Position: Q1 2026 in Review

Fortitude Family Office sold out of Rockwell Medical (RMTI) in Q1 2026, closing a stake of 50 shares — an estimated $413 sold.

Fortitude Family Office first reported a position in RMTI in Q4 2025 and held it in 1 quarter. The position peaked at $413 in Q4 2025. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • Fortitude Family Office reported no remaining Rockwell Medical position as of Q1 2026 after selling out during the quarter.
  • Fortitude Family Office sold 50 Rockwell Medical shares in Q1 2026, an estimated $413.
  • Fortitude Family Office first reported a position in Rockwell Medical in Q4 2025 and held it in 1 quarter.
  • Fortitude Family Office's Rockwell Medical position peaked at $413 in Q4 2025.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.